# Amines & Plasticizers share price today (Amines & Plasticizers Ltd, NSE: AMNPLST)

> Amines & Plasticizers share price today: ₹141.27 at the NSE close on 3 November 2026, down 35.5% in a year. Amines & Plasticizers (NSE: AMNPLST) is worth ₹778 crore, trades at a P/E of 20.2 and has closed between ₹138.45 and ₹207.05 over the past 52 weeks. > Amines & Plasticizers Ltd's share price has fallen more than its earnings. Earnings per share fell 10.9% in a year while the price moved −35.5%. AMNPLST · Speciality Chemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/amines-plasticizers-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: ₹141.27 (−35.5% in a year)
- P/E: 20.2× (lower than 59% of the last 11 years)
- Revenue (Jun 2026): ₹151 Cr (+7.3% on a year ago)
- Profit (Jun 2026): ₹9.5 Cr (+27.5% on a year ago)
- Operating margin: 9.9% (+0.7 points on a year ago)
- ROCE: 17%, FY26
- ROIC: 15.6%, against a 12.0% cost of capital: +3.6 points

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Amines & Plasticizers share price today? Amines & Plasticizers Ltd's share price was ₹141.27 at the close on 3 November 2026. It has been falling for 7 weeks. That is 22.8% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹138 and ₹207, and at that close it sat 4% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 18 weeks running. Over the last 11 years the share price moved +741% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 24 July 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Amines & Plasticizers this quarter? One change stood out: revenue grew again in the June 2026 quarter. 1. Revenue grew again in the June 2026 quarter Revenue was ₹151 crore, +7.3% on a year earlier (₹140 crore), after 3 quarters of decline. ## What are Amines & Plasticizers' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Amines & Plasticizers reported revenue of ₹151 crore, up 7.3% from ₹140 crore a year earlier, and a profit of ₹9.47 crore, up 27.5% from ₹7.43 crore. ### Amines & Plasticizers results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹151 crore | ₹140 crore | +7.3% |
| Profit | ₹9.47 crore | ₹7.43 crore | +27.5% |
| Earnings per share | ₹1.72 | ₹1.35 | +27.4% |
| Operating margin | 9.9% | 9.3% | +0.7 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Amines & Plasticizers share price history? Amines & Plasticizers closed at ₹141.27 on 3 November 2026, down 35.5% from ₹219.00 a year earlier (31 October 2025) and up 7.5% over five years. Its highest weekly close since March 2016 was ₹330.55 on 9 August 2024. ### Amines & Plasticizers share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹140.65 | +0.4% |
| 1 month ago · 1 Oct 2026 | ₹165.43 | −14.6% |
| 6 months ago · 30 Apr 2026 | ₹168.75 | −16.3% |
| 1 year ago · 31 Oct 2025 | ₹219.00 | −35.5% |
| 3 years ago · 3 Nov 2023 | ₹155.55 | −9.2% |
| 5 years ago · 4 Nov 2021 | ₹131.45 | +7.5% |
| 10 years ago · 4 Nov 2016 | ₹33.55 | +321.1% |
| Earliest and lowest weekly close in our records · 11 Mar 2016 | ₹16.80 | +740.9% |
| Highest weekly close since March 2016 · 9 Aug 2024 | ₹330.55 | −57.3% |
| 52-week high (weekly close) · 7 Nov 2025 | ₹207.05 | −31.8% |
| 52-week low (weekly close) · 27 Mar 2026 | ₹138.45 | +2.0% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (563 weekly closes from 11 March 2016 to 3 November 2026.)

## What is the latest news on Amines & Plasticizers? 3 Nov 2026: Amines & Plasticizers closed at ₹141.27, up 0.4% on the week and down 14.6% on the month. 11 Sep 2026: ex-date for a dividend of ₹0.50 a share. ### Earlier

- Results for April to June 2026: Revenue up 7.3% and profit up 27.5% on a year earlier. ## What dividend does Amines & Plasticizers pay? Amines & Plasticizers paid ₹0.50 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 0.35% at the ₹141.27 close on 3 November 2026. The last was a dividend of ₹0.50 a share, ex-date 11 September 2026. ### Amines & Plasticizers dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 11 Sep 2026 | ₹0.50 | Dividend |
| 12 Sep 2025 | ₹0.50 | Dividend |
| 13 Sep 2024 | ₹0.50 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 2 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Amines & Plasticizers Ltd paid out 8% of its profit as dividends in FY26, and it paid a dividend in 12 of its last 13 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## Which stock lists is Amines & Plasticizers on? Amines & Plasticizers is not on any of our India lists this week. ## Is Amines & Plasticizers profitable? Amines & Plasticizers Ltd earned ₹9.5 Cr of net profit in the Jun 2026 quarter, +27.5% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹37.0 Cr. Over 10 years profit has grown 15.2% a year on average. That is 6.3% of the quarter's revenue. The same quarter a year earlier earned ₹7.4 Cr. For the full year, FY26 profit was ₹37.0 Cr (−9.8% on the year before). Why profit moved: revenue changed +7.3% on a year earlier and the margin moved +0.7 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed −3.0% and revenue −11.1%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does Amines & Plasticizers make, and is it growing? Amines & Plasticizers Ltd reported ₹151 Cr of revenue in the Jun 2026 quarter, +7.3% on the same quarter a year earlier. Over 10 years it has grown 8.1% a year on average. The last full year, FY26, came in at ₹571 Cr. The last four reported quarters add to ₹581 Cr. FY26 revenue was ₹571 Cr, −13.6% on the year before. Recent pace: the last four quarters grew −11.1% on average, against 8.1% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −12.4%, against −5.3% a year over the last 8 quarters (rolling over); profit over the last 12 months grew −3.0%, against −2.5% a year (stabilising). ## How much of every ₹100 of sales does Amines & Plasticizers keep? Amines & Plasticizers Ltd's operating margin was 9.9% in the Jun 2026 quarter, 0.7 percentage points higher than the same quarter a year ago. Across 13 years it has been between 7.0% and 12.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +0.7 percentage points on the year while gross margin changed −3.6 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Amines & Plasticizers' profit turning into cash? Over the last 3 years, 120% of Amines & Plasticizers Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹66.0 Cr of operating cash against ₹37.0 Cr of profit. After ₹2.0 Cr of spending on assets, ₹64.0 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 120% of profit came in as cash: the cash cycle got 62 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does Amines & Plasticizers' cash go? Amines & Plasticizers Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 109 days in FY26, up from 47 days in FY21. It spent ₹8.0 Cr on assets over the last 3 years. Customers take 89 days to pay, and stock sits for 83 days on average. At FY26 sales of ₹571 Cr, each day of that cycle ties up about ₹1.6 Cr, so roughly ₹171 Cr is tied up in the business at any time. FY26: customers took 89 days to pay and stock sat for 83 days, about 2.7 months of sales sitting as stock, for a full cycle of 109 days, longer than FY21's 47. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 83 days. Customers pay about 89 days after that. Suppliers are paid at 62 days. Together that makes the 109-day cycle. Spending on assets: ₹8.0 Cr over the last 3 years, against ₹17.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is spending about what it takes to replace what wears out, or less. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is Amines & Plasticizers' P/E ratio, and how does it compare with its own history? Amines & Plasticizers Ltd's P/E is 20.2×, in the middle of its own history: higher than 41% of past readings. Its usual P/E (the middle reading) is 22.1×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −10.9% while the price moved −35.5%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved +1.5% a year; about +3.3% a year came from earnings growth and about −1.8 percentage points from the multiple (the market paying less); over 10 years the price moved +15.5% a year; about +15.6% a year came from earnings growth and about −0.1 percentage points from the multiple (roughly no change). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Amines & Plasticizers business getting better or worse? Amines & Plasticizers Ltd's business is giving mixed signals. Revenue, profit and EPS growth are shrinking while ROCE is steady at 19.2%, so growth and returns point different ways. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Amines & Plasticizers earn on its capital? Amines & Plasticizers Ltd earned a ROCE of 17% in FY26. That is up from a low of 16% in FY23. Its return on capital used (ROIC) is 3.6 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 6.5% net margin and 1.35× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 6.5% net margin × 1.35× asset turnover × 1.45× leverage (assets divided by equity) ≈ 12.7% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 15.6% − 12.0% = +3.6 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 15.6% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 14.4%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Amines & Plasticizers have too much debt? Amines & Plasticizers Ltd has total debt of ₹27.0 Cr against shareholder equity of ₹292 Cr as of Jun 2026, so its debt is 0.09× its equity, which is very little. Year by year, that ratio went from 0.44 in FY22 to 0.09 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Amines & Plasticizers shareholding pattern? No group of Amines & Plasticizers Ltd's owners changed its stake by a full percentage point over the last two years. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: +0.0 points over 8 quarters, to 73.2%. ## How far is Amines & Plasticizers from balance-sheet trouble? For Amines & Plasticizers Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Amines & Plasticizers rank in its industry? 41.1 out of 100, rank 26 of 30 in Speciality Chemicals, with 81% of the evidence available. Amines & Plasticizers Ltd scores 41.1 out of 100 against the 30 companies it is compared with in Speciality Chemicals, ranking 26. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 8.8 + 13.8 + 10.8 + 7.7 = 41.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Amines & Plasticizers compared with? Amines & Plasticizers ranks 26 of 30 Speciality Chemicals companies on the 4-Factor Sector Score, with 41.1 out of 100. 1. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) PANAMAPET · turning · Sector-leading setup · 96% evidence 80.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.8/35 · Revenue 45.9% · Profit 100% · Operating margin change 14 points · 88% evidence Capital efficiency 15.9/25 · ROCE 19.2% · Operating margin 22% · 100% evidence Valuation 19.7/20 · P/E 5.7× · PEG 0.18 · 100% evidence Relative strength 13.9/20 · Lead over its industry 16.3% · Lead over NIFTY 500 31.3% · 1 year 68.1% · 100% evidence · 10 of 12 weeks ahead Exact sum: 30.8 + 15.9 + 19.7 + 13.9 = 80.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) YASHO · losing its lead · Most evidence points up · 78% evidence 67.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.0/35 · Revenue 54.2% · Profit 100% · Operating margin change 3 points · 100% evidence Capital efficiency 12.3/25 · ROCE 8.9% · Operating margin 21% · 100% evidence Valuation 12.7/20 · P/E 45× · PEG 1.02 · 65% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 41.1% · 1 year 103.4% · 25% evidence · 11 of 12 weeks ahead Exact sum: 30 + 12.3 + 12.7 + 12.2 = 67.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) breaking out · Evidence leans up · 68% evidence 64.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 16.9% · Profit 41.9% · Operating margin change 8 points · 83% evidence Capital efficiency 21.3/25 · ROCE 36.2% · Operating margin 48% · 95% evidence Valuation 6.6/20 · P/E 25.8× · PEG n/a · 50% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 74.5% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.8 + 21.3 + 6.6 + 12.5 = 64.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Sunshield Chemicals Ltd](https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd) SUNSHIEL · quiet · Evidence leans up · 81% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 12.9% · Profit 100% · Operating margin change 5 points · 88% evidence Capital efficiency 18.8/25 · ROCE 19.9% · Operating margin 16% · 100% evidence Valuation 10.8/20 · P/E 24.3× · PEG 2.21 · 100% evidence Relative strength 10.8/20 · Lead over its industry n/a · Lead over NIFTY 500 4.3% · 1 year -4% · 25% evidence · 0 of 5 weeks ahead Exact sum: 23.6 + 18.8 + 10.8 + 10.8 = 64 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) BLACKROSE · quiet · Evidence leans up · 81% evidence 60.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 8.6% · Profit 28.6% · Operating margin change 6 points · 88% evidence Capital efficiency 16.4/25 · ROCE 18.7% · Operating margin 16% · 100% evidence Valuation 10.0/20 · P/E 17.1× · PEG 4.96 · 100% evidence Relative strength 10.9/20 · Lead over its industry n/a · Lead over NIFTY 500 4.4% · 1 year n/a · 25% evidence · 7 of 12 weeks ahead Exact sum: 23.6 + 16.4 + 10 + 10.9 = 60.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) TATVA · losing its lead · Evidence leans up · 93% evidence 60.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.7/35 · Revenue 49.2% · Profit 100% · Operating margin change 1 points · 100% evidence Capital efficiency 8.7/25 · ROCE 7.2% · Operating margin 19% · 100% evidence Valuation 11.3/20 · P/E 60.2× · PEG 1.21 · 65% evidence Relative strength 11.4/20 · Lead over its industry 7.8% · Lead over NIFTY 500 23.3% · 1 year 15.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 28.7 + 8.7 + 11.3 + 11.4 = 60.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Aether Industries Ltd](https://www.sectoralpha.in/stocks/aether-industries-ltd) AETHER · leader · Evidence leans up · 90% evidence 59.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 30.2% · Profit 28.4% · Operating margin change 1 points · 100% evidence Capital efficiency 12.8/25 · ROCE 11.9% · Operating margin 32% · 100% evidence Valuation 9.7/20 · P/E 85.1× · PEG n/a · 50% evidence Relative strength 14.8/20 · Lead over its industry 22.3% · Lead over NIFTY 500 38.6% · 1 year 114.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 22.4 + 12.8 + 9.7 + 14.8 = 59.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) PRIVISCL · quiet · Evidence leans up · 82% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 17.5% · Profit 44.5% · Operating margin change -1 points · 95% evidence Capital efficiency 18.5/25 · ROCE 22.3% · Operating margin 26% · 76% evidence Valuation 10.1/20 · P/E 33.7× · PEG n/a · 50% evidence Relative strength 7.1/20 · Lead over its industry -9.7% · Lead over NIFTY 500 4.2% · 1 year 10.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 23.7 + 18.5 + 10.1 + 7.1 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fineotex Chemical Ltd](https://www.sectoralpha.in/stocks/fineotex-chemical-ltd) FCL · leader · Evidence leans up · 96% evidence 59.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue 91.5% · Profit 41% · Operating margin change -2 points · 88% evidence Capital efficiency 13.5/25 · ROCE 18.3% · Operating margin 16% · 100% evidence Valuation 5.7/20 · P/E 46.1× · PEG 1.92 · 100% evidence Relative strength 19.5/20 · Lead over its industry 34.1% · Lead over NIFTY 500 48.9% · 1 year 62.9% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.3 + 13.5 + 5.7 + 19.5 = 59 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) DMCC · quiet · Evidence leans up · 93% evidence 55.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.9/35 · Revenue 72.1% · Profit 34.5% · Operating margin change -6.9 points · 100% evidence Capital efficiency 8.7/25 · ROCE 14.8% · Operating margin 4.2% · 100% evidence Valuation 16.1/20 · P/E 16.9× · PEG 0.44 · 65% evidence Relative strength 7.8/20 · Lead over its industry -12.3% · Lead over NIFTY 500 0.9% · 1 year -15.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 22.9 + 8.7 + 16.1 + 7.8 = 55.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Aarti Industries Ltd](https://www.sectoralpha.in/stocks/aarti-industries-ltd) AARTIIND · quiet · Evidence leans up · 100% evidence 55.2 out of 100 Growth Capital Valuation Relative
12. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) GALAXYSURF · leader · Evidence leans up · 81% evidence 53.9 out of 100 Growth Capital Valuation Relative
13. [Pidilite Industries Ltd](https://www.sectoralpha.in/stocks/pidilite-industries-ltd) PIDILITIND · quiet · Evidence leans up · 100% evidence 53.0 out of 100 Growth Capital Valuation Relative
14. [DIC India Ltd](https://www.sectoralpha.in/stocks/dic-india-ltd) DICIND · breaking out · Evidence leans up · 81% evidence 53.0 out of 100 Growth Capital Valuation Relative
15. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) KRONOX · breaking out · Evidence leans up · 74% evidence 51.8 out of 100 Growth Capital Valuation Relative
16. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) NEOGEN · leader · Evidence leans up · 90% evidence 51.5 out of 100 Growth Capital Valuation Relative
17. [Chemcon Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd) CHEMCON · breaking out · Evidence leans up · 85% evidence 51.1 out of 100 Growth Capital Valuation Relative
18. [Alkyl Amines Chemicals Ltd](https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd) ALKYLAMINE · quiet · Evidence leans down · 96% evidence 47.9 out of 100 Growth Capital Valuation Relative
19. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) GRAUWEIL · breaking out · Evidence leans down · 96% evidence 46.3 out of 100 Growth Capital Valuation Relative
20. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) PAUSHAKLTD · losing its lead · Evidence leans down · 85% evidence 45.8 out of 100 Growth Capital Valuation Relative
21. [Innovassynth Technologies (India) Ltd](https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd) breaking out · Too little evidence to rank firmly · 53% evidence 44.0 out of 100 Growth Capital Valuation Relative
22. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ANURAS · turning · Evidence leans down · 78% evidence 43.7 out of 100 Growth Capital Valuation Relative
23. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) PLATIND · turning · Evidence leans down · 81% evidence 42.5 out of 100 Growth Capital Valuation Relative
24. [Vinati Organics Ltd](https://www.sectoralpha.in/stocks/vinati-organics-ltd) VINATIORGA · quiet · Evidence leans down · 82% evidence 42.4 out of 100 Growth Capital Valuation Relative
25. [Amal Ltd](https://www.sectoralpha.in/stocks/amal-ltd) AMAL · quiet · Evidence leans down · 68% evidence 41.5 out of 100 Growth Capital Valuation Relative
26. Amines & Plasticizers Ltd this page AMNPLST · quiet · Evidence leans down · 81% evidence 41.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 8.8/35 · Revenue -12.4% · Profit -3% · Operating margin change 0.7 points · 88% evidence Capital efficiency 13.8/25 · ROCE 16.7% · Operating margin 9.9% · 100% evidence Valuation 10.8/20 · P/E 20.3× · PEG 1.77 · 100% evidence Relative strength 7.7/20 · Lead over its industry n/a · Lead over NIFTY 500 -15.9% · 1 year -34.7% · 25% evidence · 0 of 12 weeks ahead Exact sum: 8.8 + 13.8 + 10.8 + 7.7 = 41.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 27. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) TRANSPEK · losing its lead · Evidence leans down · 63% evidence 38.6 out of 100 Growth Capital Valuation Relative
28. [Vishnu Chemicals Ltd](https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd) VISHNU · losing its lead · Evidence leans down · 100% evidence 38.4 out of 100 Growth Capital Valuation Relative
29. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) CLEAN · breaking out · Evidence leans down · 85% evidence 38.1 out of 100 Growth Capital Valuation Relative
30. [Thirumalai Chemicals Ltd](https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd) TIRUMALCHM · quiet · Most evidence points down · 68% evidence 27.2 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Speciality Chemicals](https://www.sectoralpha.in/sectors/speciality-chemicals), all 30 compared on one page. ## Which companies are close to Amines & Plasticizers in size? Amines & Plasticizers is the 23rd largest of 30 Speciality Chemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Platinum Industries, Vikram Thermo (India) and Sunshield Chemicals. Just below it: Kronox Lab Sciences, Transpek Industry and Chemcon Speciality Chemicals. ### Speciality Chemicals companies close in size

1. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) ₹1,215 crore
2. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) ₹1,129 crore
3. [Sunshield Chemicals Ltd](https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd) ₹882 crore
4. Amines & Plasticizers Ltd ₹782 crore
5. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) ₹691 crore
6. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) ₹682 crore
7. [Chemcon Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd) ₹666 crore

[All 30 Speciality Chemicals companies, largest first](https://www.sectoralpha.in/sectors/speciality-chemicals#all-companies)

### Companies close in size in other industries

1. [TAC Infosec Ltd](https://www.sectoralpha.in/stocks/tac-infosec-ltd) ₹784 crore · IT - Software
2. [Taneja Aerospace & Aviation Ltd](https://www.sectoralpha.in/stocks/taneja-aerospace-aviation-ltd) ₹784 crore · Aviation
3. Amines & Plasticizers Ltd ₹782 crore
4. [Vision Infra Equipment Solutions Ltd](https://www.sectoralpha.in/stocks/vision-infra-equipment-solutions-ltd) ₹782 crore · Trading
5. [Sudarshan Pharma Industries Ltd](https://www.sectoralpha.in/stocks/sudarshan-pharma-industries-ltd) ₹780 crore · Trading

## What else do people ask about Amines & Plasticizers? ### What is Amines & Plasticizers's share price today? Amines & Plasticizers Ltd's share price is ₹141.27, −35.5% over the past year. The whole company is worth ₹778 Cr on the market. In the last 52 weeks it traded between ₹138 to ₹207; today it is 4% of the way up from the low, 22.8% below its 200-day average (as of 3 November 2026). ### What were Amines & Plasticizers's latest quarterly results? Amines & Plasticizers Ltd reported revenue of ₹151 Cr and net profit of ₹9.5 Cr for the Jun 2026 quarter. Revenue rose 7.3% and profit rose 27.5% compared with a year earlier. Earnings per share were ₹1.72. The operating margin was 9.9%, 0.7 percentage points higher than a year earlier (as of 3 November 2026). ### What is Amines & Plasticizers's market cap? Amines & Plasticizers Ltd's market capitalisation is ₹778 Cr at a share price of ₹141.27. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Amines & Plasticizers performing? Amines & Plasticizers Ltd's share price has been falling for 7 weeks. In its latest quarter, revenue rose 7.3% and profit rose 27.5% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 18 weeks running (as of 3 November 2026). ### Will Amines & Plasticizers's share price go up? This page does not forecast Amines & Plasticizers Ltd's share price. What it shows instead: the share price is ₹141.27, and it has been falling for 7 weeks. Its P/E of 20.2× is higher than 41% of its own last 11 years (as of 3 November 2026). ### Who owns Amines & Plasticizers? Promoters own 73.2% of Amines & Plasticizers Ltd, foreign institutions , domestic institutions, and the public 26.8% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 3 November 2026). ### Where is Amines & Plasticizers in its business cycle? Amines & Plasticizers Ltd's FY26 operating margin was 10.0%, against a 13-year range of 7.0% to 12.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 9.9%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Amines & Plasticizers story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Amines & Plasticizers a stock worth studying right now? What the numbers show: Amines & Plasticizers Ltd's share price has fallen more than its earnings. Earnings per share fell 10.9% in a year while the price moved −35.5%. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.